Circ_CEA Promotes the Interaction Between the P53 and Cyclin-Dependent Kinases 1 As a Scaffold to Inhibit the Apoptosis of Gastric Cancer.
Yuan,Xiaojing Zhang,Kaining Du,Xiaohui Zhu,Shanshan Chang,Yang Chen,Yidan Xu,Jiachun Sun,Xiaonuan Luo,Shiqi Deng,Ying Qin,Xianling Feng,Yanjie Wei,Xinmin Fan,Ziyang Liu,Baixin Zheng,Hassan Ashktorab,Duane Smoot,Song Li,Xiaoxun Xie,Zhe Jin,Yin Peng
DOI: https://doi.org/10.1038/s41419-022-05254-1
2022-01-01
Cell Death and Disease
Abstract:Circular RNAs (circRNAs) have been reported to play essential roles in tumorigenesis and progression. This study aimed to identify dysregulated circRNAs in gastric cancer (GC) and investigate the functions and underlying mechanism of these circRNAs in GC development. Here, we identify circ_CEA, a circRNA derived from the back-splicing of CEA cell adhesion molecule 5 (CEA) gene, as a novel oncogenic driver of GC. Circ_CEA is significantly upregulated in GC tissues and cell lines. Circ_CEA knockdown suppresses GC progression, and enhances stress-induced apoptosis in vitro and in vivo. Mechanistically, circ_CEA interacts with p53 and cyclin-dependent kinases 1 (CDK1) proteins. It serves as a scaffold to enhance the association between p53 and CDK1. As a result, circ_CEA promotes CDK1-mediated p53 phosphorylation at Ser315, then decreases p53 nuclear retention and suppresses its activity, leading to the downregulation of p53 target genes associated with apoptosis. These findings suggest that circ_CEA protects GC cells from stress-induced apoptosis, via acting as a protein scaffold and interacting with p53 and CDK1 proteins. Combinational therapy of targeting circ_CEA and chemo-drug caused more cell apoptosis, decreased tumor volume and alleviated side effect induced by chemo-drug. Therefore, targeting circ_CEA might present a novel treatment strategy for GC.